CYP4Z1-IN-2
CYP4Z1-IN-2 (compound 7) is a reversible inhibitor of CYP4Z1 (Ki=2.2 μM), which inhibits the production of 14,15-EET in breast cancer cells. CYP4Z1-IN-2 inhibits the CYP4Z1-mediated Luc-BE O-debenzylation reaction with an IC50 of 5.9 μM[1].
Product Specifications
CAS Number
[2428734-45-4]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Cytochrome P450
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
O=C(O)CCCCCCCNN1N=NC2=CC=CC=C21
Molecular Formula
C14H20N4O2
Molecular Weight
276.33
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Kowalski JP, et al. Design and Characterization of the First Selective and Potent Mechanism-Based Inhibitor of Cytochrome P450 4Z1. J Med Chem. 2020 May 14;63 (9) :4824-4836.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6129999-01 0.1 mL
ANKRD37 (LPR2BP, Ankyrin Repeat Domain-containing Protein 37, Low-density Lipoprotein Receptor-related Protein 2-binding Protein, MGC111507) (AP)
Ask
View Details 
MBS6129999-02 5x 0.1 mL
ANKRD37 (LPR2BP, Ankyrin Repeat Domain-containing Protein 37, Low-density Lipoprotein Receptor-related Protein 2-binding Protein, MGC111507) (AP)
Ask
View Details 
